• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

Recent Advances in the Application of 4-(2-Bromoacetyl)benzenesulfonyl Chloride (CAS 5038-59-5) in Chemical Biology and Pharmaceutical Research

4-(2-Bromoacetyl)benzenesulfonyl Chloride (CAS 5038-59-5) is a versatile chemical reagent that has garnered significant attention in recent years due to its unique reactivity and potential applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly in the development of enzyme inhibitors, covalent probes, and targeted therapeutics. The presence of both a reactive bromoacetyl group and a sulfonyl chloride moiety enables this molecule to participate in diverse chemical transformations, making it a valuable tool for researchers in drug discovery and chemical biology.

Recent studies have highlighted the utility of 4-(2-Bromoacetyl)benzenesulfonyl Chloride in the development of covalent inhibitors targeting essential enzymes in disease pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its effectiveness in creating irreversible inhibitors of cysteine proteases, which play crucial roles in various pathological conditions including cancer metastasis and inflammatory diseases. The researchers utilized the compound's ability to form stable covalent bonds with nucleophilic amino acid residues, achieving high selectivity and potency in their inhibitor designs.

In the field of chemical proteomics, 4-(2-Bromoacetyl)benzenesulfonyl Chloride has emerged as a valuable tool for activity-based protein profiling (ABPP). A recent Nature Chemical Biology publication (2024) described its use in developing novel probes for mapping enzyme activities in complex biological systems. The bromoacetyl group's reactivity towards catalytic nucleophiles, combined with the sulfonyl chloride's ability to introduce reporter tags, makes this compound particularly useful for creating multifunctional probes that can simultaneously capture and identify enzyme activities.

Pharmaceutical applications of this compound have expanded significantly, with several research groups reporting its incorporation into drug candidates targeting protein-protein interactions. A 2023 study in ACS Chemical Biology demonstrated how derivatives of 4-(2-Bromoacetyl)benzenesulfonyl Chloride could be used to develop small molecules that disrupt critical protein-protein interfaces in oncogenic signaling pathways. The compound's ability to introduce both covalent anchoring points and structural diversity has proven particularly valuable in this challenging area of drug discovery.

Recent synthetic methodology developments have further enhanced the utility of 4-(2-Bromoacetyl)benzenesulfonyl Chloride. A 2024 publication in Organic Letters described a novel one-pot procedure for its conversion into various heterocyclic scaffolds, significantly expanding the structural diversity accessible from this key intermediate. These advances have important implications for medicinal chemistry, where rapid access to diverse molecular architectures is often crucial for optimizing drug candidates.

Safety and handling considerations for 4-(2-Bromoacetyl)benzenesulfonyl Chloride remain an important research focus. Recent improvements in synthetic protocols have reduced the need for hazardous reagents in its production, while new stabilization methods have extended its shelf life for laboratory use. These developments, reported in a 2023 Chemical Research in Toxicology article, have made the compound more accessible to researchers while maintaining high standards of laboratory safety.

Looking forward, the unique chemical properties of 4-(2-Bromoacetyl)benzenesulfonyl Chloride (CAS 5038-59-5) position it as a key building block for emerging therapeutic modalities. Current research directions include its application in targeted protein degradation strategies and the development of covalent drugs with improved selectivity profiles. As these applications mature, this versatile compound is likely to play an increasingly important role in bridging chemical biology and pharmaceutical development.

• 59514-71-5(3-Phenanthrenesulfonyl chloride, 10-benzoyl-)
• 73035-17-3(5-Acetyl-2-methylbenzenesulfonyl chloride)
• 53446-32-5(1-ANTHRACENESULFONYL CHLORIDE, 9-BENZOYL-)
• 1788-10-9(4-acetylbenzenesulphonyl chloride)
• 17318-70-6(4-benzoylbenzenesulfonyl Chloride)
• 439697-11-7(3-(2-bromoacetyl)benzenesulfonyl Chloride)
• 73035-16-2(3-Acetylbenzenesulfonyl chloride)
• 1152558-85-4(3-Propanoylbenzene-1-sulfonyl chloride)
• 64062-91-5(Benzenesulfonyl chloride, 4-(2-bromoethyl)-)
• 144006-69-9(4'-Acetyl-1,1'-biphenyl-4-sulfonyl chloride)